Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Spherix Global Insights
Marketing
Off-label drugs fall out of favor in lupus
New biologics in the form of GSK’s Benlysta and AstraZeneca’s Saphnelo have nearly doubled in use for systemic lupus erythematosus since 2021.
Ben Adams
Jun 16, 2023 10:16am
Eisai's Leqembi gaining ground with US neurologists
Apr 11, 2023 10:00am
Docs 'cautious' about GSK's new anemia drug: survey
Feb 9, 2023 2:52pm
BMS' Zeposia, AbbVie drugs shake up early IBD market
Dec 6, 2022 9:25am
Biogen's Aduhelm slowly gaining steam among neurologists: study
Sep 16, 2021 12:00pm
Biohaven's marketing strategy for Nurtec ODT hits home with docs
Sep 14, 2021 10:25am